The importance of influenza vaccination during the COVID‐19 pandemic-Reference-Cited by-同舟云学术

The importance of influenza vaccination during the COVID‐19 pandemic

Published:2021-10-03 Issue:1 Volume:16 Page:3-6
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Resp Viruses

Author:

McCauley John¹^ORCID,Barr Ian G.²³^ORCID,Nolan Terry⁴⁵⁶,Tsai Theodore⁷,Rockman Steven³⁸,Taylor Beverly⁹

Affiliation:

1. Worldwide Influenza Centre The Francis Crick Institute London UK

2. WHO Collaborating Centre for Reference and Research on Influenza VIDRL Melbourne Victoria Australia

3. Department of Microbiology and Immunology, University of Melbourne Peter Doherty Institute for Infection and Immunity Melbourne Australia

4. Vaccine and Immunisation Research Group Peter Doherty Institute for Infection and Immunity Melbourne Victoria Australia

5. Department of Infectious Diseases, Melbourne Medical School The University of Melbourne Parkville Victoria Australia

6. Vaccine and Immunisation Research Group Murdoch Children's Research Institute Parkville Victoria Australia

7. Takeda Vaccines Cambridge Massachusetts USA

8. Seqirus Ltd Parkville Victoria Australia

9. Seqirus Ltd Liverpool UK

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/irv.12917

Reference19 articles.

1. Where have all the viruses gone? Disappearance of seasonal respiratory viruses during the COVID‐19 pandemic

2. Uncertain effects of the pandemic on respiratory viruses

3. UK Government.Independent report. JCVI interim advice: potential COVID‐19 booster vaccine programme winter 2021 to 2022. Published 30 June 2021. (Accessed 15 September 2021). Available from:https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022

4. Coinfection in SARS‐CoV‐2 infected patients: Where are influenza virus and rhinovirus/enterovirus?

5. World Health Organization.Weekly Epidemiological Record2021;96:77‐88.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor;mBio;2024-05-08

2. The association between influenza vaccination and the perception of COVID-19 as well as COVID-19 vaccination behavior among community residents in Anhui province, China;Human Vaccines & Immunotherapeutics;2023-11-08

3. Impact of COVID-19 Pandemic on the Influenza Vaccination and Predictors of Influenza Vaccination in Japan: A Cross-sectional Study;Journal of Public Health Management and Practice;2023-04-21

4. Antiviral Activity of Technologically Processed Antibodies to CD4 Receptor against Influenza Infection;Bulletin of Experimental Biology and Medicine;2022-12

5. Scenario modelling for diminished influenza seasons during 2020/2021 and 2021/2022 in England;2022-10-30